• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CCAR2对宫颈癌细胞中白细胞介素-8的产生起负调控作用。

CCAR2 negatively regulates IL-8 production in cervical cancer cells.

作者信息

Kim Wootae, Pyo Jaehyuk, Noh Byeong-Joo, Jeong Joo-Won, Lee Juhie, Kim Ja-Eun

机构信息

Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.

Department of Pathology, School of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.

出版信息

Oncotarget. 2017 Dec 13;9(1):1143-1155. doi: 10.18632/oncotarget.23199. eCollection 2018 Jan 2.

DOI:10.18632/oncotarget.23199
PMID:29416683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5787426/
Abstract

Cell cycle and apoptosis regulator 2 (CCAR2) is a multifaceted protein that controls diverse cellular functions; however, its function in cancer is unclear. To better understand its potential role in cancer, we examined gene expression patterns regulated by CCAR2 in cervical cancer cells. Cytokine and chemokine production by CCAR2-deficient cells increased under oxidative conditions. In particular, HO-treated CCAR2-depleted cells showed a significant increase in interleukin-8 (IL-8) production, indicating a negative regulation of IL-8 by CCAR2. Upregulation of IL-8 expression in CCAR2-deficient cells occurred via activation of transcription factor AP-1. The negative correlation between CCAR2 and IL-8 expression was confirmed by examining mRNA and protein levels in tissues from cervical cancer patients. Furthermore, CCAR2-regulated IL-8 expression is associated with a shorter survival of cervical cancer patients. Overall, the data suggest that CCAR2 plays a critical role in controlling both the cancer secretome and cancer progression.

摘要

细胞周期与凋亡调节因子2(CCAR2)是一种具有多种功能的蛋白质,可控制多种细胞功能;然而,其在癌症中的作用尚不清楚。为了更好地了解其在癌症中的潜在作用,我们研究了CCAR2在宫颈癌细胞中调控的基因表达模式。在氧化条件下,CCAR2缺陷细胞产生的细胞因子和趋化因子增加。特别是,经过氧化氢(HO)处理的CCAR2缺失细胞中白细胞介素-8(IL-8)的产生显著增加,表明CCAR2对IL-8具有负调控作用。CCAR2缺陷细胞中IL-8表达的上调是通过转录因子AP-1的激活实现的。通过检测宫颈癌患者组织中的mRNA和蛋白质水平,证实了CCAR2与IL-8表达之间呈负相关。此外,CCAR2调控的IL-8表达与宫颈癌患者较短的生存期相关。总体而言,数据表明CCAR2在控制癌症分泌组和癌症进展中起着关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac5/5787426/84217766c6be/oncotarget-09-1143-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac5/5787426/02f4eada84ec/oncotarget-09-1143-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac5/5787426/9ab830132a18/oncotarget-09-1143-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac5/5787426/235073f999d4/oncotarget-09-1143-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac5/5787426/ec0b470eceef/oncotarget-09-1143-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac5/5787426/0021f4d845d9/oncotarget-09-1143-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac5/5787426/84217766c6be/oncotarget-09-1143-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac5/5787426/02f4eada84ec/oncotarget-09-1143-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac5/5787426/9ab830132a18/oncotarget-09-1143-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac5/5787426/235073f999d4/oncotarget-09-1143-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac5/5787426/ec0b470eceef/oncotarget-09-1143-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac5/5787426/0021f4d845d9/oncotarget-09-1143-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dac5/5787426/84217766c6be/oncotarget-09-1143-g006.jpg

相似文献

1
CCAR2 negatively regulates IL-8 production in cervical cancer cells.CCAR2对宫颈癌细胞中白细胞介素-8的产生起负调控作用。
Oncotarget. 2017 Dec 13;9(1):1143-1155. doi: 10.18632/oncotarget.23199. eCollection 2018 Jan 2.
2
CCAR2/DBC1 and Hsp60 Positively Regulate Expression of Survivin in Neuroblastoma Cells.CCAR2/DBC1 和 Hsp60 正向调节神经母细胞瘤细胞中 Survivin 的表达。
Int J Mol Sci. 2019 Jan 1;20(1):131. doi: 10.3390/ijms20010131.
3
Mechanistic insights into the dual role of CCAR2/DBC1 in cancer.深入了解 CCAR2/DBC1 在癌症中的双重作用的机制见解。
Exp Mol Med. 2023 Aug;55(8):1691-1701. doi: 10.1038/s12276-023-01058-1. Epub 2023 Aug 1.
4
CCAR2 Is Required for Proliferation and Tumor Maintenance in Human Squamous Cell Carcinoma.CCAR2是人类鳞状细胞癌增殖和肿瘤维持所必需的。
J Invest Dermatol. 2017 Feb;137(2):506-512. doi: 10.1016/j.jid.2016.09.027. Epub 2016 Oct 7.
5
CCAR2/DBC1 is required for Chk2-dependent KAP1 phosphorylation and repair of DNA damage.Chk2 依赖的 KAP1 磷酸化和 DNA 损伤修复需要 CCAR2/DBC1。
Oncotarget. 2015 Jul 10;6(19):17817-31. doi: 10.18632/oncotarget.4417.
6
CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis.CCAR1 和 CCAR2 作为具有拮抗双重性的基因变色龙:临床前、人体转化和机制基础。
Cancer Sci. 2020 Oct;111(10):3416-3425. doi: 10.1111/cas.14579. Epub 2020 Aug 9.
7
Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1beta.白细胞介素17(IL-17)通过AP-1依赖性激活诱导人骨关节炎软骨细胞产生胶原酶-3:IL-17和IL-1β对AP-1成员的差异性激活
J Rheumatol. 2002 Jun;29(6):1262-72.
8
Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.核因子κB p50/p65、Fra-1和JunD的组成性激活对于前列腺癌中白细胞介素6表达失调至关重要。
Cancer Res. 2003 May 1;63(9):2206-15.
9
The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway.白细胞介素-6在人宫颈癌中的抗凋亡作用是通过PI 3-K/Akt途径上调Mcl-1来介导的。
Oncogene. 2001 Sep 13;20(41):5799-809. doi: 10.1038/sj.onc.1204733.
10
Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells.亚致死水平的氧化应激刺激Jurkat T细胞中c-jun的转录激活并抑制IL-2启动子的激活。
J Immunol. 1996 Jul 1;157(1):160-9.

引用本文的文献

1
Genetic Variants of Interleukin-8 and Interleukin-16 and Their Association with Cervical Cancer Risk.白细胞介素-8和白细胞介素-16的基因变异及其与宫颈癌风险的关联。
Life (Basel). 2025 Jan 21;15(2):135. doi: 10.3390/life15020135.
2
Human papillomavirus and cervical cancer: an insight highlighting pathogenesis and targeting strategies.人乳头瘤病毒与宫颈癌:对发病机制及靶向治疗策略的深入剖析
Virusdisease. 2022 Jun;33(2):132-154. doi: 10.1007/s13337-022-00768-w. Epub 2022 May 30.
3
Proteomics-Based Evidence for a Pro-Oncogenic Role of ESRP1 in Human Colorectal Cancer Cells.

本文引用的文献

1
A novel crosstalk between CCAR2 and AKT pathway in the regulation of cancer cell proliferation.CCAR2与AKT信号通路在调控癌细胞增殖中的新型串扰。
Cell Death Dis. 2016 Nov 3;7(11):e2453. doi: 10.1038/cddis.2016.359.
2
CCAR2 Is Required for Proliferation and Tumor Maintenance in Human Squamous Cell Carcinoma.CCAR2是人类鳞状细胞癌增殖和肿瘤维持所必需的。
J Invest Dermatol. 2017 Feb;137(2):506-512. doi: 10.1016/j.jid.2016.09.027. Epub 2016 Oct 7.
3
The CXCL8-CXCR1/2 pathways in cancer.癌症中的CXCL8-CXCR1/2信号通路。
基于蛋白质组学的证据表明 ESRP1 在人结直肠癌细胞中发挥致癌作用。
Int J Mol Sci. 2020 Jan 16;21(2):575. doi: 10.3390/ijms21020575.
4
Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.HPV 介导的炎症与宫颈癌中细胞外囊泡和 microRNAs 的致病作用:综述。
Int J Cancer. 2020 Jan 15;146(2):305-320. doi: 10.1002/ijc.32688. Epub 2019 Oct 31.
5
FPR1 mediates the tumorigenicity of human cervical cancer cells.FPR1介导人宫颈癌细胞的致瘤性。
Cancer Manag Res. 2018 Nov 16;10:5855-5865. doi: 10.2147/CMAR.S182795. eCollection 2018.
Cytokine Growth Factor Rev. 2016 Oct;31:61-71. doi: 10.1016/j.cytogfr.2016.08.002. Epub 2016 Aug 25.
4
Expression of DBC1 is associated with poor prognosis in hepatitis virus-related hepatocellular carcinoma.DBC1的表达与肝炎病毒相关肝细胞癌的不良预后相关。
Pathol Res Pract. 2016 Jul;212(7):616-21. doi: 10.1016/j.prp.2016.04.001. Epub 2016 Apr 7.
5
Positive regulation of β-catenin-PROX1 signaling axis by DBC1 in colon cancer progression.DBC1在结肠癌进展中对β-连环蛋白-PROX1信号轴的正向调控作用
Oncogene. 2016 Jun 30;35(26):3410-8. doi: 10.1038/onc.2015.401. Epub 2015 Oct 19.
6
Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma.白细胞介素-8是人类肝门部胆管癌的一个预后指标。
Int J Clin Exp Pathol. 2015 Jul 1;8(7):8376-84. eCollection 2015.
7
DBC1/CCAR2 is involved in the stabilization of androgen receptor and the progression of osteosarcoma.DBC1/CCAR2参与雄激素受体的稳定及骨肉瘤的进展。
Sci Rep. 2015 Aug 7;5:13144. doi: 10.1038/srep13144.
8
DBC1 promotes anoikis resistance of gastric cancer cells by regulating NF-κB activity.DBC1通过调节NF-κB活性促进胃癌细胞的失巢凋亡抗性。
Oncol Rep. 2015 Aug;34(2):843-9. doi: 10.3892/or.2015.4007. Epub 2015 May 28.
9
The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma.DBC1/CCAR2的表达与卵巢癌的不良预后相关。
J Ovarian Res. 2015 Feb 15;8:2. doi: 10.1186/s13048-015-0129-3.
10
DBC1 functions as a tumor suppressor by regulating p53 stability.DBC1通过调节p53稳定性发挥肿瘤抑制作用。
Cell Rep. 2015 Mar 3;10(8):1324-34. doi: 10.1016/j.celrep.2015.01.066. Epub 2015 Feb 26.